Patents
Sitemap › A01 - Agriculture; Forestry; Animal husbandry; Hunting; Trapping; Fishing › A01K - Animal husbandry; Care of birds, fishes, insects; Fishing; Rearing or breeding animals, not otherwise provided for; New breeds of animals › A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals
Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
05/2005
05/31/2005US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
05/31/2005US6900038 eNOS mutations useful for gene therapy and therapeutic screening
05/31/2005US6900032 Human PTTG polypeptide and method for producing it
05/31/2005US6900022 Prostate cancer-specific marker
05/31/2005US6899871 Gene delivery system and methods of use
05/26/2005WO2005047469A2 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
05/26/2005WO2005046452A2 A polypeptide complex that regulates cell cycle and anergy
05/26/2005WO2005046450A2 Method for diagnosis and treatment of pulmonary disorders
05/26/2005WO2004063341A3 Hematopoietic stem cell niche cells
05/26/2005US20050114916 Production of proteins in eggs
05/26/2005US20050114915 Method for sex biasing spermatozoa
05/26/2005US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies
05/26/2005US20050114912 Model for neurodegenerative disorders
05/26/2005US20050114911 Method for expressing multiple recombinant proteins in milk of transgenic non-human mammals
05/26/2005US20050114910 Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
05/26/2005US20050113303 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity
05/26/2005US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/26/2005US20050112682 Green fluorescent fusion protein as diagnosis tool; quantitative analysis; colorimetic analysis
05/26/2005US20050112681 Isolated human transporter proteins, nucleic acid molecules encoding human, transporter proteins, and uses thereof
05/26/2005US20050112574 Isolated nucleic acid; angiogenesis inhibitor
05/26/2005US20050112565 Proteases
05/26/2005US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus
05/26/2005US20050112127 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
05/26/2005CA2548080A1 Porcine isogloboside 3 synthase protein, cdna, genomic organization, and regulatory region
05/25/2005EP1532861A1 Cathepsin-associaged genetically modified nonhuman mammal
05/25/2005EP1532276A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
05/25/2005EP1532260A2 Chromosomal loci for the stringent control of gene activities via transcription activation systems
05/25/2005EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use
05/25/2005EP1532250A1 Fcyriia transgenic animal model for autoimmune disease
05/25/2005EP1532246A2 Genetic suppression and replacement
05/25/2005EP1531666A1 Inducible eukaryotic expression system
05/25/2005EP1351565A4 Chemical inhibitors of mismatch repair
05/25/2005EP0851766B1 Method for analyzing the immunosuppressant activity of ion channel blockers using the mini-pig
05/25/2005EP0479866B2 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus
05/25/2005DE202004019129U1 Genetically-modified rodent for use in established experimental systems, exhibits homozygote knock-out of interferon receptor alpha-chain
05/25/2005DE202004019128U1 Transgenic non-human mammal for laboratory investigations, has construct integrated into genome, causing inactivation of type one interferon receptor
05/25/2005CN1620508A Transgenic organism
05/25/2005CN1620498A Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability
05/25/2005CN1620468A Novel anti-igf-ir antibodies and uses thereof
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1618969A Mammalian sytokine-like polypeptide-10
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1618282A Scheme for industrial prodn. of maggot and earthworm
05/25/2005CN1618281A Method for cleaning manure, and material used therefor
05/25/2005CN1203092C Process for preparing transgenic coat producing milk containing human granulocyte-colony stimulating factor
05/24/2005US6897352 Detecting agent for use in reducing or preventing ultraviolet radiation damage; obtain transgenic rodent, expose to ultraviolet radiation, administer modulating agent, monitor rodent cell for reduced cellular damage
05/24/2005US6897045 Adeno-associated virus vectors
05/24/2005US6896579 Method and apparatus for conditioning honey bees
05/19/2005WO2005045043A1 C/ebpalpha gene targeting constructs and uses thereof
05/19/2005WO2005044974A2 Cell death-related nucleases and their uses
05/19/2005WO2005043994A1 A method for inducing the sexual maturation of lugworms
05/19/2005WO2005043993A1 Transgenic amphibian models for lymphatic vessel development
05/19/2005WO2005043992A1 Attention-deficient hyperactivity disorder (adhd) model mouse
05/19/2005WO2005043991A1 Methods for selecting gametes and for producing genetically modified non-human animals
05/19/2005WO2005033281A3 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
05/19/2005WO2005025517A9 Animal model for protease activity and liver damage
05/19/2005WO2005003786A3 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
05/19/2005US20050108785 Using nuclear transplantation as tool in generating transgenic cells for treatment and prevention of liver, nervous system, cardiovascular and bone disorders; regenerative medicine
05/19/2005US20050108784 Expression vector comprising nucleotide sequences coding spinocerebellar ataxia-1 gene for use in treatment and prevention of nervous system disorders
05/19/2005US20050108783 Porcine invariant chain protein, full length cDNA, genomic organization, and regulatory region
05/19/2005US20050108781 Expression vector comprising nucleotide sequences coding heterologous polypeptides for use as gene transfer and expression tool; bioreactors
05/19/2005US20050108779 Transgenic flies expressing Abeta42-Italian
05/19/2005US20050108048 Methods and system for managing mouse colonies
05/19/2005US20050107675 Observation window member and experimental animal having observation window
05/19/2005US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/19/2005US20050106670 Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/19/2005US20050106654 Animal model lacking histone deacetylase (HDAC) for use as diagnostic tool in detection, diagnosis and prevention of cardiac hypertrophy
05/19/2005US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators
05/19/2005US20050106567 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders
05/19/2005US20050103276 Insect holder
05/19/2005CA2543471A1 A method for inducing the sexual maturation of lugworms
05/18/2005EP1530977A1 Observation window member and experimental animal having observation window
05/18/2005EP1530632A2 Growth factor which acts through erb b-4 rtk
05/18/2005EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/18/2005CN1617930A Production of eukaryotic proteins and nucleic acid molecules in c. elegans
05/18/2005CN1616660A Promoter for regulating and controlling mouse orphan nucleus recepter and its use
05/18/2005CN1615691A Cultivating method for high quality meat chicken species
05/18/2005CN1201655C Method and device for rearing insects, especially for obtaining a secretion from fly larvae for therapeutic application
05/17/2005US6894205 Assay for toxin induced neuronal degeneration and viability in C. elegans
05/17/2005US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders
05/17/2005US6894031 Polynucleotides; in situ injection
05/12/2005WO2005042782A1 Methods for reducing seizure-induced neuronal damage
05/12/2005WO2005042753A1 Production of human glycosylated proteins in transgenic insects
05/12/2005WO2005042715A2 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
05/12/2005WO2005042693A2 Hla-e chimeric molecule
05/12/2005WO2005042576A1 Clq RELATED PROTEIN
05/12/2005WO2005041880A2 RhPV AS A MODEL FOR HPV-INDUCED CANCERS
05/12/2005WO2005041860A2 Stem cells for use in locating and targeting tumor cells
05/12/2005WO2005041650A1 TRANSGENIC FLIES EXPRESSING MUTANT Aβ42
05/12/2005WO2005041649A1 Transgenic nonhuman mammal
05/12/2005WO2005041648A1 Hyperlipemia/ hyperalbuminemia model animal
05/12/2005WO2005041647A1 Animal models of retinal tumorigenesis
05/12/2005WO2005041646A1 Teat cup for laboratory animals
05/12/2005WO2004106497A3 Imageable animal model of sars infection
05/12/2005WO2004029281A3 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050102708 Rodent model generated by continuous infusion of a Fe2+, A beta 42 and buthionine sulfoximine for use as diagnostic and therapeutic screening tool in detection and treatment of alzheimer's disease
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 341